This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Phase 3 data for PCSK9 inhibitor wows. Nat Biotechnol 31, 1057–1058 (2013). https://doi.org/10.1038/nbt1213-1057
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1213-1057
- Springer Nature America, Inc.
This article is cited by
-
PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages
Journal of Experimental & Clinical Cancer Research (2022)
-
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
BMC Neuroscience (2018)
-
Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease
Nature Genetics (2015)
-
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs
Drugs (2015)
-
Amgen and Regeneron push for a genetic renaissance in drug discovery
Nature Biotechnology (2014)